Back
Bicara Therapeutics Vs. CRISPR Therapeutics AG Industry Stock Comparison
Sell
43
BCAX
Bicara Therapeutics
Last Price:
$11.79
Seasonality Move:
--
Sell
25
CRSP
CRISPR Therapeutics AG
Last Price:
$37.79
Seasonality Move:
26.86%
Sell
43
Bicara Therapeutics (BCAX)
is a Sell
Is Bicara Therapeutics a Buy, Sell or Hold?
-
The current Bicara Therapeutics [BCAX] share price is $11.76. The Score for BCAX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
BCAX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $37.78. The Score for CRSP is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BCAX Stock Price Chart
What is Bicara Therapeutics's stock price today?
-
The Bicara Therapeutics share price today is $11.76The current trend is relatively stagnant and BCAX is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $37.78Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight buying pressure.
BCAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.61 | Sell |
Relative Strength Index (14 RSI): | 48.32 | Sell |
Chaikin Money Flow: | 343852 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.82 - 13.44) | Sell |
Bollinger Bands (100): | (11.58 - 17.74) | Sell |
CRSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.65 | Buy |
Relative Strength Index (14 RSI): | 49.49 | Sell |
Chaikin Money Flow: | 299518 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.05 - 41.49) | Buy |
Bollinger Bands (100): | (37.68 - 47.48) | Sell |
BCAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.6 | Buy |
20-day SMA: | 11.96 | Sell |
50-day SMA: | 12.71 | Sell |
200-day SMA: | 0 | Buy |
8-day EMA: | 11.21 | Buy |
20-day EMA: | 11.72 | Buy |
50-day EMA: | 12.71 | Sell |
200-day EMA: | 11.31 | Buy |
CRSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.96 | Buy |
20-day SMA: | 36.72 | Buy |
50-day SMA: | 40.94 | Sell |
200-day SMA: | 46.3 | Sell |
8-day EMA: | 36.64 | Buy |
20-day EMA: | 31.44 | Buy |
50-day EMA: | 20.09 | Buy |
200-day EMA: | 6.64 | Buy |
Bicara Therapeutics Earnings Growth & BCAX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and a decrease next year of $0.51 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.02 per share, an increase this year of $0.24 per share, and an increase next year of $0.91 per share.
Bicara Therapeutics Technical Analysis
Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
CRISPR Therapeutics AG Technical Analysis
Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |